|1.||Travis, William D: 36 articles (01/2016 - 07/2004)|
|2.||Yang, Pan-Chyr: 25 articles (07/2015 - 11/2002)|
|3.||Wistuba, Ignacio I: 25 articles (06/2015 - 04/2005)|
|4.||Nagai, Kanji: 23 articles (08/2015 - 06/2003)|
|5.||Yatabe, Yasushi: 22 articles (12/2015 - 06/2004)|
|6.||Noguchi, Masayuki: 22 articles (09/2015 - 06/2002)|
|7.||Ishii, Genichiro: 22 articles (08/2015 - 12/2006)|
|8.||Yokota, Jun: 21 articles (12/2014 - 07/2002)|
|9.||Sima, Camelia S: 20 articles (01/2016 - 05/2011)|
|10.||Kohno, Takashi: 20 articles (09/2015 - 07/2002)|
05/15/2007 - "To identify a gene signature predictive of recurrence in primary lung adenocarcinoma, we analyzed gene expression profiles in a training set of 48 node-negative tumors (stage I-II), comparing tumors from cases who remained disease-free for a minimum of 36 months with those from cases whose disease recurred within 18 months of complete resection. "
01/01/2013 - "We demonstrated significant therapeutic efficacy of Vaccinia virus treatment of both advanced lung adenocarcinoma and tumor-associated ME. "
09/01/2005 - "Our results suggest that there exist multiple molecular carcinogenesis pathways in lung adenocarcinoma that may associate with smoking habits and gender, and that genetic cancer profiling will reveal previously uncharacterized genetic heterogeneity of cancer and be beneficial in estimating patient prognosis and discovering novel cancer-related genes including therapeutic targets."
12/20/2005 - "The therapeutic efficacy of 5F11-DOX and free DOX was detected on subcutaneous or intraperitoneal exnogenic transplanted tumors of human lung adenocarcinoma A2 cells in nude mice. "
09/25/1993 - "This therapy was safe and effective for local tumor reduction in a case of hilar lung adenocarcinoma."
|2.||Neoplasm Metastasis (Metastasis)
01/01/2015 - "We, for the first time, reported that CCR9 could be beneficial in predicting lymph node metastasis, and it might act as a novel prognostic biomarker for lung adenocarcinoma."
01/01/2014 - "These findings suggest for the first time that Tiam1 expression may be beneficial in predicting lymph node metastasis and survival of patients with lung adenocarcinoma. "
10/01/2015 - "Further retrospective analyses and prospective clinical trials are required to substantiate the efficacy of afatinib in the treatment of brain metastases of lung adenocarcinoma. "
10/01/2015 - "However, the efficacy of afatinib, the second-generation irreversible EGFR TKI, as the first-line treatment in lung adenocarcinoma patients with brain metastasis has yet to be evaluated.Here"
12/01/2009 - "We aimed to evaluate prospectively the efficacy of positron emission tomography (PET)/computed tomography (CT) plus brain magnetic resonance imaging (MRI) for detecting extrathoracic metastases in lung adenocarcinoma. "
01/01/2005 - "Napsin A is superior to SP-A for distinguishing primary lung adenocarcinoma from adenocarcinomas of other organs at primary, metastatic, and recurrent sites."
08/01/2014 - "This new adenocarcinoma classification is a very useful predictive marker to plan and determine a therapeutic strategy for lung adenocarcinoma."
01/01/2015 - "The PIONEER study (NCT01185314) is a prospective molecular epidemiology study in Asian patients with newly diagnosed advanced lung adenocarcinoma, aiming to prospectively analyze EGFR mutation status in IIIB/IV treatment-naïve lung adenocarcinomas in Asia. "
02/01/2014 - "Among the 440 patients with adenocarcinoma of lung screened for this study, 46 (10.4%) harboured the EML4-ALK fusion, 90 (20.4%) harboured an activating EGFR mutation, and all had adenocarcinoma. "
01/01/2014 - "The study population consisted of 80 patients with lung adenocarcinoma, 40 patients with ovarian adenocarcinoma and 80 healthy subjects. "
|4.||Lung Neoplasms (Lung Cancer)
03/01/2015 - "Personalized therapy for non‑small cell lung cancer (NSCLC), particularly lung adenocarcinoma, has recently been significantly improved by the discovery of various molecular targets. "
06/01/2011 - "While genomically targeted therapies have improved outcomes for patients with lung adenocarcinoma, little is known about the genomic alterations which drive squamous cell lung cancer. "
02/01/2016 - "Our study suggested that HNRNPA1 might play an important role in lung adenocarcinoma cells and provided a foundation for further study into the potential of HNRNPA1 for lung cancer therapy. "
11/01/2015 - "In 2011, a new pathological classification of lung adenocarcinoma was proposed by the International Association for the Study of Lung Cancer, the American Thoracic Society and the European Respiratory Society. "
10/01/2015 - "This study investigated the prognostic value of the new International Association for the Study of Lung Cancer, American Thoracic Society, and European Respiratory Society (IASLC/ATS/ERS) lung adenocarcinoma classification in resected stage IB lung adenocarcinoma. "
|5.||Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/15/2008 - "Six specimens of lung adenocarcinoma tissues and seven specimens of lung squamous carcinoma tissues obtained during operation were made into frozen sections and stained by improved H-E solution. "
01/01/2015 - "The goal of our study was a comparative evaluation of apoptosis regulators: p53, Bcl-2, Bax, COX-2, and survivin in lung adenocarcinoma (AC) and squamous cell carcinoma (SCC). "
01/01/2015 - "We performed a pilot proteogenomic study to compare lung adenocarcinoma to lung squamous cell carcinoma using quantitative proteomics (6-plex TMT) combined with a customized Affymetrix GeneChip. "
02/01/2012 - "Goals of this study were to analyze the ability of mass spectrometry serum profiling to distinguish non-small cell lung adenocarcinoma from squamous cell carcinoma patients and healthy controls. "
01/01/2012 - "We validated MFUF chip performance using lung adenocarcinoma cell lines and then used the chip to study the electrotaxis of HSC-3, an oral squamous cell carcinoma cell line. "
|3.||erlotinib (CP 358,774)
|4.||Epidermal Growth Factor Receptor (EGF Receptor)
|9.||Glutathione (Reduced Glutathione)
|10.||DNA (Deoxyribonucleic Acid)
|1.||Drug Therapy (Chemotherapy)
|2.||Heterologous Transplantation (Xenotransplantation)
|4.||Lymph Node Excision (Lymph Node Dissection)
|5.||Combination Drug Therapy (Combination Chemotherapy)